ITN 270000000003.docx

Michigan.gov/MiProcurement

Michigan.gov/MiProcurement

NOTICE OF INTENT TO NEGOTIATE AND CONTRACT WITH A SINGLE PROVIDER

Date: 10/26/2026 The State of Michigan intends to make a purchase for which it believes there is no viable alternative. The purpose of this notice is to attempt to identify possible alternatives.

Requestor: Michigan Department of Health and Human Services

1. State Contact Information:

The sole point of contact concerning this Invitation to Negotiate is:

Wanda Rademacher, Solicitation Manager

(517) 241-0134 Rademacherw@michigan.gov

2. Description of Purchase:

The Michigan Department of Health and Human Services Bureau of Laboratories (MDHHS-BOL) is contracting with Mayo Medical Laboratories for second-tier testing of dried blood spots as well as the interpretation of the results as part of newborn screening. Testing must be for specific analytes, including:

· 17-hydroxyprogesterone, androstenedione, cortisol, 11-deoxycortisol and 21-deoxycortisol for congenital adrenal hyperplasia (CA),

· Homocysteine (total), methylmalonic acid and methylcitric acid for propionic acidemia, methylmalonic acidemia, homocystinuria, (PA/MMA/HCU),

· Heparan sulfate and dermatan sulfate for mucopolysaccharidiosis types I, II, III, IV (MPS I, II, III, IV),

· Creatine, creatinine, and activity of acid-alpha glucosidase for Pompe Disease (PD),

· Alloisoleucine, leucine, isoleucine and valine for Maple Syrup Urine Disease (MSUD),

· Hydroxyglutaric Acids, Glutaric Acid, Ethylmalonic Acid and Methylsuccinic Acid for glutaric acidemia, and

· Lysophosphatidylcholines by Liquid Chromatography-Tandem Mass Spectrometry for X-linked adrenoleukodystrophy (X-ALD).

Mayo Medical Laboratories (MML) is the only service provider who conducts these tests on dried blood spots and provides the appropriate methodology and interpretation to meet the needs of the MDHHS laboratory.

3. Commodity Code References: 94855 Medical and Laboratory Services (Non-Physician)

4. Description of Action: New contract for a minimum of three years with five, one-year options.

5. Intended Source: Mayo Medical Laboratories (Mayo Collaborative Services, Inc. Vendor # CV0050311). Address: P. O. Box 9146, Minneapolis MN 55480-9146.

6. Questions:

Questions concerning the Invitation to Negotiate must be e-mailed to rademacherw@michigan.gov no later than 10/28/2026 3:00pm EST. In the interest of transparency, only written questions will be accepted. Answers to questions will be posted on www.michigan.gov/SIGMAVSS.

Responders should submit their questions using the following format:

7. Response Deadline:

Any potential bidder who does not agree that this good or service is available only from the intended source, must submit a response in SIGMA by 11/2/2026 1:59pm EST. Your response must be in writing and describe the product or service you are offering as an equivalent.

image1.png